| Identification | Back Directory | [Name]
2043659-93-2 | [CAS]
2043659-93-2 | [Synonyms]
Cevidoplenib dimesylate,B-cell,anti-inflammatory,Syk,immunomodulating,neutrophils,macrophages,Inhibitor,Spleen tyrosine kinase,inhibit
Methanone, cyclopropyl[5-?[[4-?[4-?[[(4S)?-?4-?hydroxy-?2-?isoxazolidinyl]?methyl]?-?3-?methyl-?1H-?pyrazol-?1-?yl]?-?2-?pyrimidinyl]?amino]?-?1-?methyl-?1H-?indol-?3-?yl]?-?, methanesulfonate (1:2) | [Molecular Formula]
C26H31N7O6S | [MOL File]
2043659-93-2.mol | [Molecular Weight]
569.64 |
| Hazard Information | Back Directory | [Uses]
Cevidoplenib is an orally available inhibitor of spleen tyrosine kinase (Syk), with potential anti-inflammatory and immunomodulating activities[1][2]. | [References]
[1] International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 31, No. 4, 2017.
[2] cevidoplenib dimesylate. |
|
|